The strange case of TGN1412 L. FarzanehN. KasaharaF. Farzaneh Editorial 17 June 2006 Pages: 129 - 134
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine Matthew T. HuemanAlexander StojadinovicGeorge E. Peoples Original Article 17 June 2006 Pages: 135 - 146
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody Yunfeng ZhaoMichael RussSybille Muller Original Article 03 August 2006 Pages: 147 - 154
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma D. RitchieL. MileshkinH. M. Prince Original Article 30 May 2006 Pages: 155 - 163
Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen Sumia AliKate MulryanPeter L. Stern Original Article 07 June 2006 Pages: 165 - 180
Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin Hai LianNingyi JinPing Li Original Article 10 June 2006 Pages: 181 - 192
Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells Simona VertuaniEugenia DubrovskaJelena Levitskaya Original Article 03 June 2006 Pages: 193 - 204
Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10 Mingzhong ZhengDora BocangelSunil Chada Original Article 19 May 2006 Pages: 205 - 215
Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice Arthur MachlenkinRonit Azriel-RosenfeldLea Eisenbach Original Article 01 June 2006 Pages: 217 - 226
Immune selective pressure and HLA class I antigen defects in malignant lesions Chien-Chung ChangSoldano Ferrone Original Article 17 June 2006 Pages: 227 - 236
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model Mariano F. Zacarías FluckMaría J. RicoO. Graciela Scharovsky Original Article 30 May 2006 Pages: 237 - 248
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients Alfred ZippeliusAsma GatiDirk Jaeger Original Article 23 May 2006 Pages: 249 - 258
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules Tomoko SoTakeshi HanagiriPierre G. Coulie Original Article 07 June 2006 Pages: 259 - 269